Location Palo Alto, California, United States Regions San Francisco Bay Area, Silicon Valley, West Coast Gender Male
LinkedIn View on LinkedIn
Clint Webb is the Co-Founder and COO at GEn1E Lifesciences Inc., which is focused on transforming promising research into therapies to address areas of huge unmet medical need. He previously served as COO of MK EnterprisesInc., a privately held business conglomerate; VP of Legal at OXiGENE, Inc., VP, General Counsel and Corporate Secretary at
Genelabs Technologies, Inc. (Acquired by GlaxoSmithKline); Corporate and Licensing Counsel at Ilypsa, Inc. (Acquired by Amgen); Licensing Counsel at Symyx Technolgies Inc.; and Associate Attorney with Morrison & Foerster, LLP.
Mr. Webb is also a regular speaker at the U.C. Davis King Hall School of Law, where he lectures on corporate and securities laws.
In 1998, Mr. Webb received a J.D. degree from the U.C. Davis King Hall School of Law, where he was a Member of the U.C. Davis Law Review and a Sr. Articles Editor of the Journal of International Law and Policy.
In 1991, Mr. Webb received a B.A. degree in English Literature from U.C. Berkeley.
Legal generalist with experience leading teams and/or projects in matters ranging from public and private company corporate governance, finance, securities, intellectual property licensing and employment matters. Solid leadership and communication skills.
